Related Experiment Video
Updated: Aug 16, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Cardiovascular Complications in Kidney Transplant Recipients with COVID-19: A Case Series
Ankita Patil1, Nikhil Rao1, Kruteesh Kumar1
1Department of Nephrology, Seth G. S. Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Insights
Kidney transplant recipients with COVID-19 face severe cardiovascular risks, including heart attacks and myocarditis, even with low cardiovascular risk. Early recognition and management are crucial for survival in these vulnerable patients.
Area of Science:
- Nephrology
- Cardiology
- Infectious Diseases
Background:
- Kidney transplant recipients (KTRs) exhibit increased vulnerability to severe COVID-19.
- COVID-19 infection in KTRs is linked to significant cardiovascular complications.
Observation:
- A study observed five KTRs with COVID-19 experiencing severe cardiovascular events.
- These events included ST-segment myocardial infarction (STEMI), myocarditis, atrial fibrillation, and cardiogenic shock.
- Coronary angiography in STEMI patients showed no signs of atherosclerotic coronary artery disease.
Findings:
- Four out of five patients had low cardiovascular risk based on Framingham scores.
- Inflammatory markers peaked during the cardiovascular events in most patients.
- Myocardial injury and arrhythmias occurred in KTRs due to severe COVID-19, independent of traditional CV risk factors.
Implications:
- KTRs with COVID-19 require vigilant cardiovascular monitoring, irrespective of their baseline CV risk.
- Severe COVID-19 can precipitate acute cardiac events in KTRs through non-atherosclerotic mechanisms.
- This highlights the need for tailored management strategies for cardiovascular complications in immunosuppressed populations during viral pandemics.
Abstract:
Kidney transplant recipients (KTRs) are at a higher risk for developing severe COVID-19 which can be associated with cardiovascular complications. We studied five KTRs recipients infected with COVID-19 who developed severe cardiovascular complications. Two patients presented with ST segment myocardial infarction and two with clinically suspected myocarditis. One patient presented with atrial fibrillation. Two of these patients developed cardiogenic shock. Inflammatory markers were at peak during the event in four of these who had presented with severe COVID-19. Coronary angiography done in two patients with STEMI did not reveal any evidence of atherosclerotic coronary artery disease. Also, based on the cardiovascular (CV) risk estimation by Framingham score, four patients had low CV risk and one patient had intermediate CV risk. All five patients survived. Even with low CV risk, KTRs can develop myocardial injury and arrhythmias solely because of severe COVID-19.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations

